Principal Study Investigator Discusses Rigel's ITP Therapy ApprovalByJames Bussel, M.D.April 20th 2018The FDA approved fostamatinib disodium hexahydrate (Tavalisse) tablets for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia. RDR discusses with Dr James Bussel.